Boldenone Undecylenate (“Equipoise”) Overview:
Boldenone Undecylenate, commonly known as “Equipoise,” is a veterinary injectable steroid derived from testosterone, renowned for its potent anabolic and moderately androgenic properties. With the undecylenate ester prolonging its activity, injections are typically administered every three to four weeks. Widely used in veterinary medicine for horses, Equipoise enhances lean bodyweight, appetite, and overall disposition. Athletes have also embraced Equipoise as an alternative to Deca-Durabolin, appreciating its ability to provide steady gains in strength and high-quality muscle mass over longer cycles.
Contents:
Each ampoule contains 200mg/ml of Boldenone undecylenate, offering a potent formulation for muscle enhancement.
Side Effects:
Equipoise exhibits mild side effects, with a lower propensity for estrogen conversion compared to testosterone. While water retention and estrogenic effects are possible, they are typically manageable with moderate dosages. Gynecomastia may occur in sensitive individuals or at higher dosages, but can often be mitigated with adjunctive medications like Nolvadex or anti-aromatases.
Administration:
To maintain stable blood levels, Equipoise should be injected at least once per week. Common dosages range from 400-600mg per week for men and 50-150mg weekly for women, ensuring optimal results with minimal risk of side effects.
